PROJECT INFORMATION


March 18, 2016:
Project Factsheet:
ENGLISH / GERMAN / FRENCH

factsheets

VIDEO


As part of the SYMPATH project a video was developed to inform people about the project and related themes.

The video concept was to address the following topics:
• Parkinson’s disease is a progressive neurodegenerative disorder without cure
• α-Synuclein is the molecular cause of the disease
• SYMPATH targets α-Synuclein to develop a disease modifying therapy
• Clinical testing of this therapeutic approach is currently conducted within SYMPATH

 

 PHOTO BOOK


As a reminder of the many positive outcomes resulting from the SYMPATH FAHR-MIT event and to attract support for future events, it was decided to immortalise these events in the form of a commemorative photographic reportage book documenting the entire event from conception through to the invited reception at Vienna City Hall. Biolution prepared this book from the many photographs, quotes and collected media reports generated during the tour.

The digital version of the photobook is available here.

 

 PUBLICATIONS


Articles published in scientific journals:

Multiple System Atrophy – State of the Art.
Laurens et al. 2017
D.O.I. 10.1007/s11910-017-0751-0

Nanoparticle standards for immuno-based quantitation of α-synuclein oligomers in diagnostics of Parkinson’s disease and other synucleopathies.
Herrmann et al., 2017
D.O.I 10.1016/j.cca.2017.01.010

Active immunization therapies for Parkinson’s disease and multiple system atrophy.
Schneeberger et al., 2016
D.O.I. 10.1002/mds.26377

Targeting α-synuclein for treatment of Parkinson’s disease: mechanistic and therapeutic considerations.
Dehay et al., 2015
D.O.I. 10.1016/S1474-4422(15)00006-X

Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy.
Mandler et al., 2015
D.O.I. 10.1186/s13024-015-0008-9

Targeting α-synuclein: Therapeutic options.
Dehay et al., 2015
D.O.I. 10.1002/mds.26568

Articles published in the popular press:
Vaccines to take on Alzheimer‘s and Parkinson’s.  

PRESS RELEASES


June 07, 2017:
Top Line Results of AFFITOPE® PD03A Clinical Study 
ENGLISH

June 06, 2015:
SYMPATH-FAHR-MIT – Wien, Wien
GERMAN

June 05, 2015:
SYMPATH-FAHR-MIT – Niederösterreich, Krems
GERMAN

June 04, 2015:
SYMPATH-FAHR-MIT – Niederösterreich, Amstetten
GERMAN

June 03, 2015:
SYMPATH-FAHR-MIT – Oberösterreich, Linz
GERMAN

 

June 02, 2015:
SYMPATH-FAHR-MIT – Salzburg, Salzburg
GERMAN

June 01, 2015:
SYMPATH-FAHR-MIT – Tirol, Kufstein
GERMAN

May 31, 2015:
SYMPATH-FAHR-MIT – Tirol, Innsbruck
GERMAN

May 11, 2015:
SYMPATH-FAHR-MIT – FAHRRADSTAFFEL
GERMAN

December 09, 2014:
Parkinson’s Vaccine EU-Team Launches Clinical Trial
ENGLISH / GERMAN

April 28, 2014:
Parkinson’s Vaccine – Top Experts Unite in European Consortium
ENGLISH / GERMAN

 PRESS PHOTOS